Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Irradiation abolishes smooth muscle investment into vascular lesions in specific vascular beds
Alexandra A.C. Newman, … , Olga A. Cherepanova, Gary K. Owens
Alexandra A.C. Newman, … , Olga A. Cherepanova, Gary K. Owens
Published August 9, 2018
Citation Information: JCI Insight. 2018;3(15):e121017. https://doi.org/10.1172/jci.insight.121017.
View: Text | PDF
Research Article Vascular biology

Irradiation abolishes smooth muscle investment into vascular lesions in specific vascular beds

  • Text
  • PDF
Abstract

The long-term adverse effects of radiotherapy on cardiovascular disease are well documented. However, the underlying mechanisms responsible for this increased risk are poorly understood. Previous studies using rigorous smooth muscle cell (SMC) lineage tracing have shown abundant SMC investment into atherosclerotic lesions, where SMCs contribute to the formation of a protective fibrous cap. Studies herein tested whether radiation impairs protective adaptive SMC responses during vascular disease. To do this, we exposed SMC lineage tracing (Myh11-ERT2Cre YFP+) mice to lethal radiation (1,200 cGy) followed by bone marrow transplantation prior to atherosclerosis development or vessel injury. Surprisingly, following irradiation, we observed a complete loss of SMC investment in 100% of brachiocephalic artery (BCA), carotid artery, and aortic arch lesions. Importantly, this was associated with a decrease in multiple indices of atherosclerotic lesion stability within the BCA. Interestingly, we observed anatomic heterogeneity, as SMCs accumulated normally into lesions of the aortic root and abdominal aorta, suggesting that SMC sensitivity to lethal irradiation occurs in blood vessels of neural crest origin. Taken together, these results reveal an undefined and unintended variable in previous studies using lethal irradiation and may help explain why patients exposed to radiation have increased risk for cardiovascular disease.

Authors

Alexandra A.C. Newman, Richard A. Baylis, Daniel L. Hess, Steven D. Griffith, Laura S. Shankman, Olga A. Cherepanova, Gary K. Owens

×

Figure 4

Radiation induces DNA damage only in BCA SMCs but does not result in increased apoptosis or proliferation.

Options: View larger image (or click on image) Download as PowerPoint
Radiation induces DNA damage only in BCA SMCs but does not result in inc...
(A and B) Lethal radiation exposure results in significantly more TUNEL+YFP+ cells within the brachiocephalic artery (BCA) at day 1 and 4 after radiation. (C–E) SMCs do not show increased TUNEL+ cells in the media of the coronary (C), aortic root (D), or pulmonary vessels (E). (F) There was no difference in the number of YFP+ cells in the media of the BCA. (G) There was no difference in the number of cleaved caspase-3+YFP+ cells in the media of the BCA. (H) Nor was there any change in the number of cells incorporating BrdU following lethal radiation exposure. Data were assessed by Mann Whitney U test. Data represent mean ± SEM. Sample number is indicated in the graph. Scale bar: 25μm.

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts